Thromboembolism in brain tumors

Current Opinion in Pulmonary Medicine

Volumn 7, Issue 5, 2001, Pages 326-331

  Walsh, Daniel C ^a   Kakkar, Ajay K ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; WARFARIN;

ANTICOAGULATION; BRAIN HEMORRHAGE; BRAIN TUMOR; DEEP VEIN THROMBOSIS; HEMOFILTRATION; HYPERCOAGULABILITY; NEUROLOGIC DISEASE; PROPHYLAXIS; REVIEW; RISK FACTOR; THROMBOEMBOLISM; VEIN THROMBOSIS;

EID: 0034810576     PISSN: 10705287     EISSN: None     Source Type: Journal    
DOI: 10.1097/00063198-200109000-00013     Document Type: Review

References (54)

1. Tumours of the nervous system
2. Abnormalities of blood coagulation in patients with cancer: Fibrinopeptide a generation and tumour growth
3. Pathways of coagulation/fibrinolysis activation in malignancy
4. Venous thromboembolism after brain tumor surgery: A retrospective review
5. Venous thromboembolism in neurosurgery and neurology patients: A review
6. Venous thromboembolism and cancer
7. The use of heparin for treating human malignancies
8. Activation of blood coagulation in cancer: Trousseau's syndrome revisited
9. Heparin and cancer
10. Haemostatic changes during surgery for primary brain tumours
11. The coagulant and anticoagulant blood systems in brain tumors of supratentorial localization
12. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis
13. Expression of tissue factor in glioma
14. Expression of tissue factor correlates with grade of malignancy in human glioma
15. Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression
16. Tissue factor in microvesicles shed from U87MG human glioblastoma cells induces coagulation, platelet aggregation, and thrombogenesis
17. Human brain pericytes differentially regulate expression of procoagulant enzyme complexes comprising the extrinsic pathway of blood coagulation
18. Postoperative venous thromboembolism and brain tumours II: Haemostatic profile
19. Plasma fibrinolytic profile in patients with brain tumours
20. Heparin-steroid conjugates lacking glucocorticoid or mineralocorticoid activities inhibit the proliferation of vascular endothelial cells
21. Mechanism of action of angiostatic steroids: Suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis
22. Inhibition of human endothelial cell proliferation by heparin and steroids
23. Steroid inhibition of neural microvessel morphogenesis in vitro: Receptor mediation and astroglial dependence
24. Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endothelial cells
25. Correlation of intraluminal thrombosis in brain tumor vessels with postoperative thrombotic complications: A preliminary report
26. Pre-operative plasma levels of soluble fibrin polymers correlate with the development of deep vein thrombosis after elective neurosurgery
27. Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy: Risk analysis using medicare claims data
28. Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism-duration of anticoagulation trial
29. Venous thromboembolism and cancer
30. Incidence of risk of thromboembolism during treatment high-grade gliomas: A prospective study
31. The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer
32. Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study
33. Chemotherapy for malignant brain tumors of astrocytic and oligodendroglial lineage
34. Oligodendroglioma
35. Multidisciplinary management of adult anaplastic astrocytomas
36. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up of two randomized trials
37. Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: Reduction in local treatment failure
38. Oral Anticoagulation in patients with gynecological cancer and radiotherapy: A retrospective analysis of 132 patients
39. Surgery, tamoxifen, carboplatin and radiotherapy in the treatment of newly diagnosed glioblastoma patients
40. Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: A phase II study
41. Thromboembolic events during chemotherapy for germ cell cancer: A cohort study and review of the literature
42. Enoxaparin plus compression stockings compared with compression stockings alone in the prevention of venous thromboembolism after elective neurosurgery
43. Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery
44. Prophylaxis against thromboembolism in neurosurgical patients: A survey of current practice in the United Kingdom
45. Low-molecular-weight and unfractionated heparin for prevention of venous thromboembolism in neurosurgery: A meta-analysis
46. Safety of perioperative subcutaneous heparin for prophylaxis of venous thromboembolism in patients undergoing craniotomy
47. Deep vein thrombosis and low-dose heparin prophylaxis in neurosurgical patients
48. Postoperative intracerebral hemorrhages: A survey of computed tomographic findings after 1074 intracerebral operations
49. Postoperative extradural hematomas: Computed tomographic survey of 1105 intracranial operations
50. Management of intracranial bleeding associated with anticoagulation: Balancing the risk of further bleeding against thromboembolism from prosthetic heart valves
51. Intracranial traumatic and non-traumatic haemorrhagic complications of warfarin treatment
52. Vena caval filters: A comprehensive review
53. Inferior vena cava filters in cancer patients: Indications and outcome
54. Complications of therapy for venous thromboembolic disease in patients with brain tumors